Corona Remedies Limited, incorporated in August 2004, develops, manufactures, and markets pharmaceutical products. The company’s diverse portfolio featured 71 brands as of June 30, 2025, focused on women’s healthcare, cardio-diabetes, pain, urology, and other specialties.
Its nationwide reach is driven by 2,671 medical representatives across 22 states, facilitating strong engagement with the medical community. Production is handled at two Gujarat-based plants with a total annual capacity of 1,285.44 million units.
The initial public offering (IPO) for Corona Remedies is a book-built issue scheduled to open on December 8, 2025, and close on December 10, 2025. Priced between ₹1,008 and ₹1,062 per share, the IPO aims to raise approximately ₹655.37 crores through a combination of a fresh issue and an offer for sale of up to 61,71,101 equity shares, each with a face value of ₹10. The allocation is reserved with 35% for retail investors, 50% for qualified institutional buyers (QIBs), and 15% for high net-worth individuals (HNIs).
The basis of allotment is expected on December 11, 2025, followed by the listing on both the BSE and NSE on December 15, 2025. Financially, the company has demonstrated strong growth, with revenue rising to ₹1,202.35 crores in 2025 from ₹1,020.93 crores in 2024, and profit increasing to ₹149.43 crores from ₹90.50 crores over the same period.
Corona Remedies IPO Details
| IPO Date | December 8, 2025 to December 10, 2025 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| IPO Price Band | ₹1008 to ₹1062 Per Share |
| Issue Price | ₹1062 per share |
| Lot Size | 14 Shares |
| Total Issue Size | Approx ₹655.37 Crores |
| Offer for Sale | Approx 61,71,101 Equity Shares |
| Issue Type | Book building IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 6,11,60,088 shares |
| Share Holding Post Issue | 6,11,60,088 shares |
Corona Remedies IPO Dates
The initial public offering (IPO) for Corona Remedies will open on Monday, December 8, 2025, and will close on Wednesday, December 10, 2025.
| IPO Open Date | Mon, Dec 8, 2025 |
| IPO Close Date | Wed, Dec 10, 2025 |
| Tentative Allotment | Thu, Dec 11, 2025 |
| Refunds | Fri, Dec 12, 2025 |
| Credit of Shares to Demat | Fri, Dec 12, 2025 |
| Tentative Listing Date | Mon, Dec 15, 2025 |
| UPI Mandate Confirmation Deadline | 5 PM on Wed, Dec 10, 2025 |
Corona Remedies IPO Market Lot
The minimum application for the IPO is set at one lot of 14 shares, priced at ₹14,868. The upper limit for retail investors is 13 lots, equivalent to 182 shares, for a maximum amount of ₹1,93,284.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 14 | ₹14,868 |
| Retail Maximum | 13 | 182 | ₹1,93,284 |
| S-HNI Minimum | 14 | 196 | ₹2,08,152 |
| S-HNI Maximum | 67 | 938 | ₹9,96,156 |
| B-HNI Minimum | 68 | 952 | ₹10,11,024 |
